DrThomas Beaver

Pulse Biosciences’ CellFX® nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System for treatment of Atrial Fibrillation (AF) during concomitant cardiac surgery

Evaluation of the GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of RBT-1 on Reducing the Risk of Post-Operative Complications in Subjects Undergoing Cardiac Surgery (The PROTECT Study)” and “Clinical Protocol REN-007E – Extension Study: An Evaluation of Patient Reported Outcomes and Clinical Outcomes Through 12 Months Post-Cardiac Surgery in Patients Enrolled in Study REN-007”

Evaluation of the GORE® Ascending Stent Graft in the Treatment of Lesions of the Ascending Aorta GORE® Ascending Stent Graft (ASG device)

Tracking Results of Ablations to Combat AF Registry

Evolut EXPAND TAVR II Pivotal Trial

Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial

Multicenter Data Registry for Outcomes of Inappropriate Sinus Tachycardia and Postural Orthostatic Tachycardia Syndrome Treatment

Hybrid Epicardial and Endocardial Sinus-Node SpAring AbLation Therapy for Inappropriate Sinus Tachycardia

INSPIRIS RESILIA Aortic Valve Valve-in-Valve Surveillance Study

Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation

Thoracoscopic Ablation With Appendage Ligation Versus Medical Therapy for Stoke Prevention in Patients with Atrial Fibrillation: Long-Term Outcomes

Thoracic/Cardio Surg Ed & Res

A prospective, randomized, active (warfarin) controlled, parallel-arm clinical trial to determine if participants with an On-X aortic valve can be maintained safely and effectively on the factor Xa inhibitor apixaban (PROACT Xa)

A Randomized, Double-Blinded, Controlled, Parallel Group, Non-inferiority, Phase III Study to Evaluate the Efficacy and Safety of the INTERCEPT Blood System for Red Blood Cells in Patients undergoing Complex Cardiac Surgery Procedures (the ReCePI stud

A Phase 2 Proof of Concept, Double-blind, Randomized, Placebo Controlled Study to Evaluate the Efficacy of ASP1128 (MA-0217) in Subjects at Risk for Acute Kidney Injury following Coronary Artery Bypass Graft (CABG) and/or Valve Surgery

A Phase 2 Study to Assess the Effect of a Repeated Dose of Exeporfinium Chloride (XF-73) Nasal Gel on the Microbiological Burden of Commensal Staphylococcus aureus Nasal Carriage in Surgical Patients at Risk of Post-Operative Staphylococcal Infections

Prospective non-randomized single arm multi-center evaluation of the durability of aortic bioprostheses/valves with RESILIA tissue in subjects under 65

A Multicenter, Prospective, Parallel-Group, Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study of BB3 to Assess the Safety and Efficacy of BB3 in Patients Developing Acute Kidney Injury after Cardiac Surgery

Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveiLance for patients with AsYmptomatic Severe Aortic Stenosis: Early TAVR Trial

The effect of intermittent hemidiaphragm stimulation during surgery on mitochondrial function, single fiber contractile force and catabolic pathways in humans

TCV Clinical Trials Operating Account - Salary

The NGAL test as an aid in the risk assessment for AKI stage II and III in an intensive care population

A randomized, double-blind, placebo controlled, phase 2 study to evaluate the efficacy and safety of QPI-1002 for the prevention of acute kidney injury in subjects at high risk for AKI following cardiac surgery

A Prospective, Randomized, Controlled, Multi-Center Study to Establish the Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients Requiring Aortic Valve Replacement who have Severe, Calcific, Symptomatic Aortic Steno